Chemosensitivity predicted by BluePrint 80-gene functional subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)
about
The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients.Selecting postoperative adjuvant systemic therapy for early stage breast cancer: A critical assessment of commercially available gene expression assays.Molecular subtyping improves diagnostic stratification of patients with primary breast cancer into prognostically defined risk groups.Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy.Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular SubtypingMethods for Studying MicroRNA Expression and Their Targets in Formalin-Fixed, Paraffin-Embedded (FFPE) Breast Cancer Tissues.Neoadjuvant chemotherapy in breast cancers.Using a gene expression signature when controversy exists regarding the indication for adjuvant systemic treatment reduces the proportion of patients receiving adjuvant chemotherapy: a nationwide study.Clinical Overestimation of HER2 Positivity in Early Estrogen and Progesterone Receptor-Positive Breast Cancer and the Value of Molecular Subtyping Using BluePrint.Are online prediction tools a valid alternative to genomic profiling in the context of systemic treatment of ER-positive breast cancer?Genomic Impact of Neoadjuvant Therapy on Breast Cancer: Incomplete Response is Associated with Altered Diagnostic Gene Signatures.Pertuzumab/Trastuzumab/CT Versus Trastuzumab/CT Therapy for HER2+ Breast Cancer: Results from the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST).Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial.Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort Study.Luminal A Breast Cancer and Molecular Assays: A ReviewPrognostic role of tumor budding in breast cancer
P2860
Q33630465-F6158E2C-81CF-43CB-8983-231E9335B229Q33834198-78D36194-2EAA-4392-B708-81F4F9307FB4Q36210173-204C3FE2-AD82-4745-9C45-ABEDF7290805Q36762314-3216E10A-D937-4C90-84C2-ACF14B049C16Q37639271-E800A22B-1578-4015-BB8B-3BAB1DDF8ED8Q38382024-11BF643A-360E-4B88-A801-A20CD5A9B676Q39019234-E6FB905F-4551-46FB-B291-B8BB7879A495Q41113513-EA68D6C3-D28E-4D67-BE7C-DF90CC56F65EQ41443052-E2C81DF4-4C80-4F69-817E-0AEC50284F56Q41611004-E1339DFD-BCC7-43BC-97DD-42D3801A0411Q42495798-6FB60A2E-9476-4839-B2A5-E015921FABB8Q42508971-B3B06791-FA66-4133-90C7-8B7014AA0061Q42515438-787EB7E3-3B52-4625-BE1C-94A7BA3CA0E0Q54940119-220ECA5B-B631-460F-B4F5-876C414113FDQ57113322-9FD57450-3DB7-47B9-9894-9112FF9B1C48Q57159896-BE9EF7CB-49EA-4C86-8A76-B704C102B10C
P2860
Chemosensitivity predicted by BluePrint 80-gene functional subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Chemosensitivity predicted by ...... egistry Symphony Trial (NBRST)
@ast
Chemosensitivity predicted by ...... egistry Symphony Trial (NBRST)
@en
Chemosensitivity predicted by ...... Breast Registry Symphony Trial
@nl
type
label
Chemosensitivity predicted by ...... egistry Symphony Trial (NBRST)
@ast
Chemosensitivity predicted by ...... egistry Symphony Trial (NBRST)
@en
Chemosensitivity predicted by ...... Breast Registry Symphony Trial
@nl
prefLabel
Chemosensitivity predicted by ...... egistry Symphony Trial (NBRST)
@ast
Chemosensitivity predicted by ...... egistry Symphony Trial (NBRST)
@en
Chemosensitivity predicted by ...... Breast Registry Symphony Trial
@nl
P2093
P2860
P1476
Chemosensitivity predicted by ...... egistry Symphony Trial (NBRST)
@en
P2093
Angela Mislowsky
Bichlien Nguyen
Charles Nash
Femke A de Snoo
James V Pellicane
Jennifer Beatty
Lisette Stork-Sloots
Mark Gittleman
Michael Rotkis
P2860
P2888
P304
P356
10.1245/S10434-014-3908-Y
P577
2014-08-07T00:00:00Z
P5875
P6179
1026850864